Introduction – The Liver
The liver is a very significant organ in the human body that performs a series of complex operations. Mostly located in the upper—right quadrant of the abdomen, the liver holds the ability to execute five-hundred individual functions.
The liver carries up to 10% of a human being’s blood volume at any given time, bringing the average adult liver to a weight of around 1.4kgs1-.
The liver is customary for detoxifying drugs, alcohol, and other harmful matter from the gut1. Nutrient-rich blood cells are transported from the heart and intestine to the liver to deliver carbohydrates, fats and vitamins that help the liver to produce blood plasma proteins, cholesterol and vitamin D that are essential for daily bodily function2. Any old or spent blood cells are eliminated by the liver in order to produce bile salts and store vitamin A1.
The liver also produces multiple hormones as well as coagulation factors that control blood thickness in order to reduce blood clotting which may lead to cardiac arrest or a cerebrovascular accident
With the liver playing such an important role in the daily maintenance of the human body, it is crucial that we find out how to preserve it in order to live a healthy life.
Breakdown of The Hepatic Lobule
The liver is made up of four lobes.
The right lobe, left lobe, Quadrate lobe, and the Caudate lobe. These sectors are made up of thousands of small lobules that are key in the liver’s operation.
Hepatic lobules are made up from hepatocyte cells, endothelial cells, Kupffer cells, (known as resident macrophages of the liver) and Hepatic Stellate Cells (HSCs).
Chronic Liver Disease (CLD) & Immune Response
CLD is caused when repeated damage to the liver strikes the inflammation process of the immune system. When damage, most commonly through toxin abuse (e.g. alcohol or drugs), excessive fat intake (steatohepatitis) or viral hepatitis, is taken out constantly over a prolonged period of time, the liver’s regeneration capabilities become inefficient, leaving signs of fibrosis – a deposition of scar tissue in place of a dead hepatocyte.
The latest stage of CLD is called cirrhosis, this is the process in which fibrosis is too widespread to revert, increasing the chances of tumours and/or hepatic cancer.
When damage is discovered in the liver, the human body establishes a localised defensive response called inflammation6. Inflammation can be identified when a damaged area begins to swell and rise in temperature, as well as releasing cellular fluid in order to kill heat sensitive bacteria or viruses–.
Inflammation is also characterised by symptoms such as; reddening and/or loss of function of the affected area8.
Inflammation holds a vital role in the resolution of CLD as it is an early sign of fibrosis. Chronic liver damage can be easily identified through biopsies as liver tissue may show several signs of this process, helping doctors to assist in the recovery process of CLD patients during the early stages. (Figure 1)
Figure 1: Cellular changes among chronic liver inflammation – The following diagram of the liver lobule presents the activation of resident Kupffer cells as a result of hepatocyte damage, releasing factors that send quiescent HSCs into an activated state in order to release vitamin A and provoke fibrotic tissue production. The presence of fibrotic tissue leads to loss of endothelial fenestrae, and microvilli in hepatocytes. This change in cell structure may induce loss of organ function.
Image source: Iredale J.P., J Clin Invest. 2007;117(3):539-548.
Present Hepatic Cell Therapy
Current chronic liver damage treatment consists of supportive care and Orthotopic Liver Transplantations (OLTs). However, only 78% of CLD patients received these transplants within two years of listing in 2016. This combined with the risk of organ rejection shows that finding a more ideal therapy is crucial for the survival of CLD patients.
Haematopoietic immune cells of the body called macrophages are a key component in the resolution of liver damage (Figure 2).
Infiltrating macrophages are derived by circulating monocytes and hold the function to change their cellular properties according to their exposed environment–. Their role is to migrate to the affected area, phagocytose (eat and decompose) any dead cells and bacteria within an organ, and secrete (reproduce and discharge) cytokines and growth factors which assist hepatocyte proliferation.
Resident macrophages of the liver- also known as Kuppfer cells– are relatively immobile compared to infiltrating macrophages. They phagocytose microorganisms, cellular debris and other harmful bacteria that may translocate from the blood and gut to the liver where they may cause sepsis13-14.
Figure 2: Alveolar macrophages stained with Wright-Giemsa.
Cellular Communication in the Resolution of Liver Injury
Once infiltrating macrophages phagocytose dead tissue, it is digested into tiny pieces and translocated on molecules to the macrophage surface where they can be recognised by lymphocytes such as B and T cells.
T cells assist infiltrating macrophages to kill antigens, whereas B cells help to produce antibodies in order to neutralise them14-.
For the liver lobule to return to a healthy condition, activated HSCs must either encounter cell death or revert to a quiescent state as hepatocytes proliferate to substitute for the dead cell(s).
If macrophages were alone in the resolution process, not much would get done. It is the communication between cells that make the process possible.
Figure 3: Cellular communication in the resolution of liver injury
[Image source: Koyama Y., Brenner D.A. – 2017 – Liver inflammation and fibrosis – Figure 2]
Monocytes, B & T cells, Hepatocytes, and HSCs all communicate well with macrophages in order for them to do their job and execute the repair of damaged tissue. (Figure 3)
Implanting more of these extremely intellectual cells into a chronically damaged liver could possibly speed up the resolution process and aid reversal of liver damage, leaving the implantation of infiltrating macrophages as a viable cell therapy for CLD–.
Therapeutic Implantations for the Resolution of Liver Injury
Current research into viable cell therapies for chronic liver damage is based on autologous/allogeneic cell transplantation or bioartificial support systems to reverse damage or to be used while a patient is waiting for an OLT.
Primary Hepatocyte Transplantation Studies taken out on rodent models have shown that replacing dead hepatocytes with healthy reengineered hepatocytes using a direct implantation procedure via the splenic or portal veins have shown encouraging results of liver regeneration18-.
The implantation of bioartificial hepatocytes may show promising results as; it is easier for macrophages to focus on regenerating other dead cells, speeding up the resolution process.
Although this therapy may sound promising, it does hold several downsides too such as; Hepatocytes lacking the ability to migrate to the damaged area, leaving a high margin for human error and a high demand for expensive biomaterials, and hepatocytes losing the ability to proliferate after alteration and shortly after encountering cell death.
Hepatic Organoid Implantation
Recent research has led to the possible implanting of stem-cell derived bioengineered mini-livers called organoids.
Organoids are developed through the allogeneic biopsy of a healthy liver lobule. Stem cells are extracted via the bile ducts of the lobule where they are grown using the organoid culture method. The organoid is then injected into the hepatic bloodstream where its progenitor-like properties induce hepatocyte growth and reduce liver damage21-. Although hepatic organoids have shown very promising results on rodent models, slow production speed limits this procedure to rodent models for the time being, and due to this new procedure being rather invasive, can only be performed once within a human’s lifespan22-. (For more information on the pros and cons of organoid technology, seeTable 1)
Table 1: Pros and cons of organoid technology
[Table source: Nantasanti S. et al – 2015 – Concise Review: Organoids Are a Powerful Tool for the Study of Liver Disease and Personalized Treatment Design in Humans and Animals]
Human Monocyte Derived Macrophage Transplantation
Several scientists at the University of Edinburgh executed murine experiments in order to investigate the possible use of Human Monocyte-Derived Macrophages (HMDMs) as cell therapy for alcoholic/drug-induced liver cirrhosis.
Human monocytes from a healthy donor were isolated and matured into macrophages over a seven-day period using a Good Manufacturing Practice-compatible technique and were signalled as fully developed macrophages once there was an absence of monocyte markers and a presence of macrophage markers. HMDMs were then infused in mice models of toxin- induced liver fibrosis24.
Results of the experiment show markers of a significant increase in liver regeneration from fibrosis measured with Sirius red staining of the collagen25.
These findings demonstrate why we should expand this experiment to human test subjects to ascertain whether or not the implanting of HMDMs would make a functioning alternative to the current therapies on offer.
 Campana L. -2018- Inflammation and liver disease: the strange case of Dr Jekyll and Mr Hyde – Page 14
 Bryce E. – 2014 – What does the liver do? [TEDEd Video Lesson]
 U.S. Department of Health and Human Services – National Heart, Lung and Blood Institute – 2018 – Treatment – Goals of Treatment
 Hansen J.T. – 2014 – Netter’s Anatomy Coloring Book, 2nd Edition – Chapter 8, Plate 8-9
 Campana L. – 2018- Inflammation and liver disease: the strange case of Dr Jekyll and Mr Hyde – Page 15
 Campana L. – 2018- Inflammation and liver disease: the strange case of Dr Jekyll and Mr Hyde – Page 11
 Bryce E. – 2018 – How does your immune system work? [TEDEd Video Lesson]
 Campana L. – 2018 – Inflammation and liver disease: the strange case of Dr Jekyll and Mr Hyde – Page 20
 Campana L. – 2018 – Inflammation and liver disease: the strange case of Dr Jekyll and Mr Hyde – Page 34
 NHS Blood and Transplant – 2016 – Annual report on liver transplantation – Executive Summary – Page 5
 Campana L. – 2018 – Inflammation and liver disease: the strange case of Dr Jekyll and Mr Hyde – Page 25
 Ramachandran P., Iredale J.P. – 2012 – Liver Fibrosis: a bidirectional model of fibrogenesis and resolution – Page 815
 Campana L. – Message to Bryan Formosa – 22:02 GMT, 19 November 2018 – Brightside Mentoring VLE
 Campana L. – 2018- Inflammation and liver disease: the strange case of Dr Jekyll and Mr Hyde – Page 27
 FuseSchool – Global Education – 2018 – What are Antibodies | Biology for All | FuseSchool [YouTube Video]
 Campana L. – 2018 – Inflammation and liver disease: the strange case of Dr Jekyll and Mr Hyde – Page 28
 Jung Y. K., Yim H.J. – 2018 – Reversal of liver cirrhosis: current evidence and expectations. – EXPERIMENTAL EVIDENCE OF THE REGRESSION OF FIBROIS
 Nicolas C. et al – 2017 – Cell therapy in Chronic Liver Disease – Key Points
 Nicolas C. et al – 2017 – Cell therapy in Chronic Liver Disease – Cell Therapy
 Kim Y., Uygun B.E. – 2014 – Regenerative medicine applications in organ transplantation – Liver regeneration
 Hubrecht Institute – 2015 – Clevers group: Lever organoids (YouTube Video)
 Campana L. – Message to Bryan Formosa – 23:20 GMT, 02 December 2018 – Brightside Mentoring VLE
 Campana L. – Message to Bryan Formosa – 17:01 GMT, 27 December 2018 – Brightside Mentoring VLE
 Moore J.K. et al – 2015 – Cytotherapy – Phenotypic and functional characterization of macrophages with therapeutic potential generated from human cirrhotic monocytes in a cohort study – Abstract – Page 1604
 Moore J.K. et al – 2015 – Cytotherapy – Phenotypic and functional characterization of macrophages with therapeutic potential generated from human cirrhotic monocytes in a cohort study – Results – Page 1608
Cite This Work
To export a reference to this article please select a referencing stye below:
Related ServicesView all
DMCA / Removal Request
If you are the original writer of this essay and no longer wish to have your work published on the NursingAnswers.net website then please: